Leukemia is a type of blood cancer that affects the bone marrow and blood-forming tissues, leading to the abnormal production of white blood cells. Early diagnosis and timely treatment are essential because leukemia can progress rapidly and affect multiple organs and body systems.
For many Sri Lankan patients, India has become a preferred destination for leukemia treatment because of advanced hematology programs, experienced hemato-oncologists, bone marrow transplant facilities, and access to modern cancer therapies. Fortis Hospitals is among the leading healthcare networks in India offering comprehensive leukemia diagnosis, treatment, and long-term follow-up care.
What Is Leukemia?
Leukemia develops when abnormal blood cells, usually white blood cells, begin multiplying uncontrollably in the bone marrow. These abnormal cells interfere with the body's ability to produce healthy blood cells, increasing the risk of infections, anemia, and bleeding complications.
Common symptoms may include:
- Persistent fatigue
- Frequent infections
- Unexplained fever
- Easy bruising or bleeding
- Bone or joint pain
- Swollen lymph nodes
- Weight loss
- Night sweats
- Shortness of breath
Because many symptoms can resemble other medical conditions, proper diagnostic evaluation is critical.
Types of Leukemia
The treatment approach depends on the specific type of leukemia diagnosed.
Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia (ALL) is a rapidly progressing blood cancer that develops when immature lymphocytes (a type of white blood cell) multiply uncontrollably in the bone marrow. It is the most common type of leukemia in children, but it can also occur in adults. Because ALL progresses quickly, treatment usually begins soon after diagnosis.
Common symptoms may include persistent fever, fatigue, frequent infections, bone pain, easy bruising, and swollen lymph nodes. Treatment often involves multiple phases of chemotherapy, targeted therapies for specific genetic abnormalities, and in some cases, bone marrow transplantation. With advances in treatment, many patients can achieve long-term remission, particularly when diagnosed early.
Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML) is an aggressive form of leukemia that affects myeloid cells, which normally develop into red blood cells, white blood cells, and platelets. In AML, abnormal cells accumulate rapidly in the bone marrow, preventing the production of healthy blood cells.
AML is more commonly diagnosed in adults and older individuals, although it can occur at any age. Symptoms often include severe fatigue, recurrent infections, unexplained bleeding, shortness of breath, and fever. Treatment typically involves intensive chemotherapy, targeted therapies, and for selected high-risk patients, stem cell transplantation. Genetic testing plays a crucial role in determining prognosis and selecting the most appropriate treatment strategy.
Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL) is a slow-growing leukemia that affects mature lymphocytes. Many patients are diagnosed during routine blood tests before any symptoms appear. Unlike acute leukemias, CLL may progress gradually over several years.
Some patients may not require immediate treatment and can be monitored through a "watch and wait" approach until signs of disease progression develop. When treatment becomes necessary, options may include targeted therapies, immunotherapy, chemotherapy, or combination treatments. Modern targeted medications have significantly improved long-term disease control and quality of life for many CLL patients.
Chronic Myeloid Leukemia (CML)
Chronic Myeloid Leukemia (CML) is a blood cancer associated with a specific genetic abnormality known as the Philadelphia chromosome. This mutation leads to the production of an abnormal protein that causes uncontrolled growth of leukemia cells.
One of the major breakthroughs in leukemia treatment has been the development of targeted therapies called tyrosine kinase inhibitors (TKIs), which specifically block the abnormal protein responsible for CML. Many patients can now achieve excellent disease control and maintain a near-normal quality of life with long-term medication. Regular monitoring through molecular testing helps doctors assess treatment response and make adjustments when necessary.
Why Identifying the Leukemia Type Is Important
Determining the exact type of leukemia is one of the most important steps in treatment planning. Each subtype behaves differently, progresses at a different rate, and responds to different therapies. Advanced diagnostic tests such as flow cytometry, bone marrow analysis, cytogenetic testing, and molecular profiling help hemato-oncologists select the most effective treatment strategy and provide a more accurate prognosis for each patient.
How Is Leukemia Diagnosed?
Accurate diagnosis helps doctors determine the leukemia subtype, disease stage, and most appropriate treatment strategy.
Blood Tests
Doctors evaluate blood cell counts and identify abnormal blood cells through specialized laboratory testing. Bone Marrow Biopsy
A bone marrow sample is collected to confirm the diagnosis and determine the type of leukemia present.
Flow Cytometry
This advanced laboratory technique helps identify specific leukemia cell characteristics.
Cytogenetic and Molecular Testing
Genetic testing helps detect chromosomal abnormalities and molecular markers that influence treatment decisions.
Imaging Studies
CT scans, PET scans, or other imaging tests may be used to assess disease involvement in certain cases.
Leukemia Treatment Options at Fortis Hospitals
Leukemia treatment at Fortis Hospitals is delivered through dedicated hemato-oncology and bone marrow transplant programs that combine advanced diagnostics, personalized treatment planning, and multidisciplinary cancer care. Before treatment begins, specialists perform detailed blood tests, bone marrow analysis, molecular profiling, and genetic testing to identify the leukemia subtype and develop an individualized treatment strategy. The treatment plan depends on several factors, including the type of leukemia, genetic mutations, patient age, overall health, treatment history, and disease progression.
Chemotherapy
Chemotherapy remains one of the primary treatment options for many leukemia patients treated at Fortis Hospitals. Hemato-oncology specialists use evidence-based chemotherapy protocols tailored to specific leukemia subtypes such as Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML).
Treatment may involve:
- Induction therapy to achieve remission
- Consolidation therapy to eliminate remaining leukemia cells
- Maintenance therapy for long-term disease control
- Combination chemotherapy protocols for high-risk cases
Throughout treatment, patients receive close monitoring, supportive care, infection management, blood product support, and regular assessments to evaluate treatment response and minimize complications.
Targeted Therapy
Fortis Hospitals offers advanced targeted therapies for leukemia patients whose cancers contain specific molecular or genetic abnormalities. Through cytogenetic and molecular testing, specialists identify mutations that may respond to precision medicines.
Targeted therapy is commonly used for:
- Chronic Myeloid Leukemia (CML)
- Philadelphia chromosome-positive ALL
- Certain relapsed or high-risk leukemia cases
These medications help block the specific pathways that leukemia cells use to grow and survive. Compared to traditional chemotherapy, targeted therapies often provide more precise disease control with fewer effects on healthy cells and can significantly improve long-term outcomes for selected patients.
Immunotherapy
Fortis Hospitals incorporates modern immunotherapy approaches into leukemia treatment when clinically appropriate. Immunotherapy helps the body's immune system recognize and attack leukemia cells more effectively.
Depending on the patient's condition, treatment options may include:
- Monoclonal antibody therapies
- Immune-targeted treatments
- Advanced cellular therapies through specialized referral programs
- Emerging immunotherapy protocols for relapsed leukemia
The hemato-oncology team carefully evaluates eligibility based on disease subtype, genetic profile, previous treatments, and overall health status.
Bone Marrow Transplant (Stem Cell Transplant)
One of the most advanced leukemia treatment services available at Fortis Hospitals is its Bone Marrow Transplant (BMT) program. For patients with high-risk leukemia, recurrent disease, or poor response to conventional therapies, a stem cell transplant may provide the best opportunity for long-term remission or cure.
The transplant program includes:
- Comprehensive transplant evaluation
- HLA typing and donor matching
- Autologous stem cell transplantation
- Allogeneic stem cell transplantation
- Pediatric and adult transplant services
- Post-transplant monitoring and infection management
Dedicated transplant units, specialized nursing teams, infection-control protocols, and multidisciplinary support services help improve patient safety throughout the transplant journey.
Precision Diagnostics and Personalized Treatment Planning
A major advantage of leukemia treatment at Fortis Hospitals is the integration of advanced diagnostics into treatment planning. Specialists use:
- Flow cytometry
- Cytogenetic analysis
- Molecular testing
- Minimal residual disease (MRD) monitoring
- Bone marrow evaluation
These technologies help doctors understand the biology of the disease, monitor treatment effectiveness, identify recurrence risks, and adjust therapies when needed.
Multidisciplinary Hemato-Oncology Care
Leukemia treatment often requires collaboration between multiple specialists. At Fortis Hospitals, patients benefit from coordinated care involving:
- Hemato-oncologists
- Bone marrow transplant specialists
- Pathologists
- Molecular diagnostics experts
- Infectious disease specialists
- Critical care teams
- Rehabilitation and supportive care professionals
This multidisciplinary approach ensures that patients receive comprehensive care throughout diagnosis, treatment, recovery, and long-term follow-up. and adult leukemia cases.
Why Bone Marrow Transplant May Be Recommended
A bone marrow transplant is not required for every leukemia patient. However, for certain high-risk cases, it can offer the best opportunity for long-term remission or even cure. Hemato-oncology specialists at Fortis Hospitals carefully evaluate disease characteristics, genetic findings, treatment response, age, and overall health before recommending a transplant. The decision is typically made after extensive diagnostic testing and multidisciplinary review.
High-Risk Disease Features
Some leukemia patients are diagnosed with genetic mutations or chromosomal abnormalities that are associated with a higher risk of treatment failure or disease recurrence. Even when initial chemotherapy successfully induces remission, these high-risk features may increase the likelihood that leukemia cells will return in the future. In such cases, doctors may recommend a bone marrow transplant while the patient is in remission to reduce relapse risk and improve long-term survival outcomes. Advanced molecular testing performed during diagnosis helps specialists identify which patients may benefit most from early transplant consideration.
Relapsed Leukemia
Relapsed leukemia occurs when the disease returns after a patient has previously achieved remission. This can happen months or even years after successful initial treatment. Relapsed leukemia is often more challenging to treat because the remaining cancer cells may have developed resistance to earlier therapies. For many patients with recurrent leukemia, a bone marrow transplant becomes an important treatment option because it provides a new
Patient Outcomes and Survival Factors
Leukemia outcomes depend on several important factors:
Early Diagnosis
Patients diagnosed earlier often have more treatment options and improved outcomes.
Leukemia Subtype
Some leukemia types respond better to treatment than others.
Genetic Characteristics
Molecular and genetic findings play a major role in determining prognosis.
Treatment Response
Patients who achieve remission early generally experience better long-term outcomes.
Access to Specialized Care
Treatment at experienced hemato-oncology centers can significantly influence outcomes.
Estimated Leukemia Treatment Cost in India
Treatment costs vary depending on the leukemia type, treatment duration, medications, hospitalization requirements, and transplant needs.
| Treatment | Cost (INR) | Cost (USD) |
|---|---|---|
| Hematology Consultation | ₹1,000 – ₹5,000 | $12 – $58 |
| Bone Marrow Biopsy | ₹15,000 – ₹50,000 | $175 – $580 |
| Chemotherapy Cycle | ₹20,000 – ₹2,00,000+ | $235 – $2,325+ |
| Targeted Therapy | ₹50,000 – ₹3,00,000+ | $580 – $3,490+ |
| Immunotherapy | ₹1,00,000 – ₹5,00,000+ | $1,160 – $5,815+ |
| Bone Marrow Transplant | ₹15,00,000 – ₹40,00,000+ | $17,440 – $46,510+ |
Actual costs vary based on hospital, treatment complexity, donor matching requirements, medications, ICU stay, and supportive care needs.
Why Patients Choose Fortis Hospitals
Specialized Hemato-Oncology Programs
Fortis Hospitals has dedicated teams focused on blood cancers and bone marrow disorders.
Bone Marrow Transplant Expertise
Specialized transplant units manage complex leukemia cases requiring stem cell transplantation.
Advanced Diagnostic Capabilities
Modern molecular testing and genetic profiling support personalized treatment planning.
Comprehensive Cancer Care
Patients can access diagnostics, chemotherapy, targeted therapy, immunotherapy, transplant services, and follow-up care within the same healthcare network.
International Patient Services
Dedicated support teams assist overseas patients with appointments, treatment planning, and travel coordination.
How Karetrip Helps International Patients Seeking Leukemia Treatment at Fortis Hospitals
Leukemia treatment often involves multiple consultations, specialized diagnostic tests, chemotherapy cycles, prolonged hospital stays, and in some cases, bone marrow transplantation. For international patients, especially those traveling from Sri Lanka, navigating a complex healthcare journey in another country can be overwhelming. While Fortis Hospitals provides advanced medical care, Karetrip helps patients manage the entire treatment journey from the initial medical review to post-treatment follow-up—making access to care more convenient, organized, and cost-effective.
Access to the Right Leukemia Specialist from the Beginning
One of the biggest challenges for international patients is identifying the most appropriate specialist. Through Karetrip, patients can share their medical records, blood reports, bone marrow biopsy results, and treatment history before traveling.
The Karetrip team helps connect patients with the most suitable hemato-oncologists and bone marrow transplant specialists at Fortis Hospitals based on their specific diagnosis, whether it is AML, ALL, CML, CLL, or relapsed leukemia. This helps patients avoid unnecessary consultations and reach the right specialist faster.
Medical Report Review and Treatment Planning Before Travel
Many patients travel to India without fully understanding their treatment requirements, expected hospital stay, or overall treatment roadmap. Karetrip helps coordinate preliminary medical reviews so patients can receive guidance regarding:
- Likely treatment options
- Additional tests that may be required
- Estimated treatment duration
- Potential transplant eligibility
- Expected hospitalization requirements
This allows patients and families to plan their travel and finances more effectively before arriving in India.
Better Treatment Planning and Cost Transparency
Leukemia treatment costs can vary significantly depending on the diagnosis, medications, chemotherapy protocols, transplant requirements, and length of stay. Karetrip helps patients understand the expected treatment pathway and provides greater clarity regarding potential expenses.
This allows families to:
- Prepare realistic treatment budgets
- Understand major cost components
- Avoid unexpected treatment delays
- Plan accommodation and travel expenses more effectively
For many international patients, having this information beforehand reduces stress and helps them make informed healthcare decisions.
Medical Visa and Documentation Support
Obtaining a medical visa often requires multiple supporting documents, invitation letters, treatment records, and travel paperwork. Karetrip assists patients throughout the documentation process, helping ensure that applications are completed accurately and efficiently.
Support may include:
- Guidance on medical visa requirements
- Coordination of hospital invitation letters
- Documentation review
- Assistance for accompanying attendants or caregivers
This helps patients focus on treatment rather than administrative processes.
Affordable Accommodation and Local Support
Leukemia treatment often requires extended stays in India, particularly for patients undergoing chemotherapy, targeted therapy, immunotherapy, or bone marrow transplantation. Finding suitable accommodation near the hospital can be challenging for overseas families.
Karetrip helps patients identify accommodation options based on:
- Budget
- Duration of stay
- Distance from Fortis Hospitals
- Family requirements
- Long-term treatment needs
This support can help reduce overall travel expenses and improve comfort during treatment.
Airport Pickup and Travel Coordination
International travel can be physically exhausting for leukemia patients, especially those undergoing active treatment. Karetrip assists with transportation planning, including airport pickups and local travel coordination, helping patients travel safely and comfortably between accommodations, hospitals, and treatment centers.
Support During Bone Marrow Transplant Treatment
Patients undergoing bone marrow transplantation often face one of the most complex treatment journeys in cancer care. The process may involve donor evaluation, prolonged hospitalization, infection-control precautions, recovery monitoring, and multiple follow-up visits.
Karetrip helps families navigate this process by coordinating appointments, managing logistics, supporting accommodation planning for caregivers, and assisting with ongoing communication throughout the treatment period.
Continued Support After Returning Home
Leukemia treatment does not end when a patient leaves the hospital. Long-term monitoring, medication adjustments, laboratory tests, and follow-up consultations are often required for months or even years.
Karetrip helps patients stay connected with their Fortis treatment team by coordinating:
- Follow-up consultations
- Virtual doctor appointments
- Report sharing
- Ongoing treatment communication
- Long-term care planning
| Fortis Hospitals Provides | Karetrip Adds Value By |
|---|---|
| Expert leukemia treatment | Helping patients find the right specialist quickly |
| Advanced diagnostics and transplant services | Coordinating report reviews before travel |
| Chemotherapy and transplant programs | Helping patients understand treatment pathways |
| International patient services | Providing personalized end-to-end treatment coordination |
| Hospital-based care | Supporting travel, accommodation, visa, and logistics |
| Follow-up consultations | Facilitating ongoing communication after returning home |
Why Patients Connect with RUA
Many patients connect with RUA through Karetrip for personalized support throughout their treatment journey. RUA helps simplify communication with hospitals, coordinate appointments, assist with travel planning, manage accommodation arrangements, and support follow-up care after treatment.
Conclusion
Leukemia is a complex blood cancer that requires timely diagnosis, specialized treatment, and continuous monitoring to achieve the best possible outcomes. Advances in chemotherapy, targeted therapy, immunotherapy, and bone marrow transplantation have significantly improved survival rates and treatment success for many leukemia patients. However, choosing the right hospital and treatment team remains one of the most important decisions in the patient's journey.
Fortis Hospitals has established itself as a trusted destination for leukemia treatment by offering comprehensive hemato-oncology services, advanced diagnostic capabilities, personalized treatment plans, and specialized bone marrow transplant programs. With access to experienced specialists and modern treatment technologies, patients can receive coordinated care tailored to their specific leukemia subtype and medical needs.
For Sri Lankan patients seeking treatment in India, combining expert medical care at Fortis Hospitals with end-to-end support from Karetrip can make the process more convenient and less stressful. From specialist consultations and treatment planning to visa assistance, accommodation arrangements, and follow-up coordination, Karetrip helps patients focus on what matters most receiving the right treatment and working toward recovery.
Medical Disclaimer
This article is intended for informational and educational purposes only and should not be considered medical advice. Leukemia treatment plans, costs, outcomes, and survival rates vary depending on the patient's diagnosis, disease subtype, genetic characteristics, age, and response to treatment. Patients should consult qualified hemato-oncology specialists for personalized medical guidance.